Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature

Systematic Reviews

A. Porath¹  L. Esmaeilisaraji²  C. Hamel²  B. Skidmore²  M. Hersi²  D. Rice³  B. Hutton⁴  G. Garber⁵  K. Corace⁶  B. Sproule⁷  P. Macpherson⁸  R. Ortiz Nunez⁹  M. Willows^1,10  J. Flores-Aranda^1,11 

[1] Canadian Center on Substance Use and Addiction, Ottawa, ON, Canada;Center for Practice Changing Research, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Box 201b, 501 Smyth Road, K1H 8 L6, Ottawa, Ontario, Canada;Center for Practice Changing Research, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Box 201b, 501 Smyth Road, K1H 8 L6, Ottawa, Ontario, Canada;Department of Psychology, McGill University, Montreal, Quebec, Canada;Center for Practice Changing Research, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Box 201b, 501 Smyth Road, K1H 8 L6, Ottawa, Ontario, Canada;Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada;School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada;Center for Practice Changing Research, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Box 201b, 501 Smyth Road, K1H 8 L6, Ottawa, Ontario, Canada;School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada;Public Health Ontario, Toronto, ON, Canada;Center for Practice Changing Research, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Box 201b, 501 Smyth Road, K1H 8 L6, Ottawa, Ontario, Canada;Substance Use and Concurrent Disorders Program, The Royal Ottawa Mental Health Centre, Ottawa, Ontario, Canada;Department of Psychiatry, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada;Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada;Department of Pharmacy, Centre for Addiction and Mental Health, Toronto, ON, Canada;Leslie Dan Faculty of Pharmacy and Department of Psychiatry, University of Toronto, Toronto, ON, Canada;Division of Infectious Diseases, The Ottawa Hospital, Ottawa, ON, Canada;Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada;Max Ottawa, Ottawa, ON, Canada;Substance Use and Concurrent Disorders Program, The Royal Ottawa Mental Health Centre, Ottawa, Ontario, Canada;Department of Psychiatry, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada;Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada;Department of Family Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada;Université du Quebec, Montreal, QC, Canada;

关键词: Methamphetamine;    Methamphetamine addiction;    Methamphetamine use disorder;    Psychosocial treatment;    Pharmacologic treatment;    Scoping review;    Knowledge synthesis;   

DOI  :  10.1186/s13643-020-01499-z

来源: Springer

【 摘 要 】

BackgroundMethamphetamine use and harms are rising rapidly. Management of patients with methamphetamine use disorder (MUD) and problematic methamphetamine use (PMU) is challenging, with no clearly established best approach; both psychosocial and pharmacologic interventions have been described. Furthermore, given the diversity of individuals that use methamphetamines, there is a need to assess evidence for treatments for subgroups including youths; gay, bisexual, and other men who have sex with men; individuals with mental health comorbidities; and individuals in correction services. Establishing awareness of the messages regarding treatment from recent clinical practice guidelines (CPG) in the field is also of value.The first study objective will be to establish a greater understanding of the methods, populations, and findings of controlled studies for psychosocial and pharmacologic treatments for MUD and PMU. Investigation of this information can help establish the potential for advanced syntheses of the evidence (such as network meta-analysis) to compare therapies for this condition and to identify gaps related to key populations where more primary research is needed. Summarizing the recommendations regarding treatment of MUD/PMU from recent CPGs and systematic reviews will be an important secondary objective.MethodsA scoping review will be performed. Using the OVID platform, MEDLINE, Embase, PsycINFO, and relevant Cochrane databases from EBM Reviews will be searched (from databases’ inception onwards). Eligibility criteria will include individuals described as having MUD or PMU, with designs of interest including randomized trials, non-randomized trials, and controlled cohort studies with three or more months of follow-up; systematic reviews and CPGs will also be sought. Two reviewers (with support from automation tools) will independently screen all citations, full-text articles, and chart data. Different approaches to handling and summarizing the data will be implemented for each type of study design. Tables and graphics will be used to map evidence sources and identify evidence gaps.DiscussionThis research will enhance awareness of evidence addressing the effects of psychosocial and pharmacologic interventions for MUD/PMU overall and in sub-populations, both in terms of recent CPGs/reviews and primary studies; inspection of the latter will also help establish the feasibility of future syntheses to compare treatments, such as network meta-analysis.Systematic review protocol registrationOpen Science Framework (https://osf.io/9wy8p)

【 授权许可】

CC BY